GH
TGTX icon

GAM Holding’s TG Therapeutics TGTX Stock Holding History

GAM Holding’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-98,600
Closed -$552K – 887
2018
Q3 		$552K Hold
98,600
– – 0.02% 644
2018
Q2 		$1.3M Hold
98,600
– – 0.05% 386
2018
Q1 		$1.4M Hold
98,600
– – 0.05% 365
2017
Q4 		$809K Hold
98,600
– – 0.02% 634
2017
Q3 		$1.17M Hold
98,600
– – 0.05% 336
2017
Q2 		$991K Buy
98,600
+44,400
+82% +$497K 0.01% 647
2017
Q1 		$631K Buy
+54,200
New +$389K 0.01% 747

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GAM Holding's TGTX Position: Q4 2018 in Review

GAM Holding sold out of TG Therapeutics (TGTX) in Q4 2018, closing a stake of 98,600 shares — an estimated $552K sold.

GAM Holding first reported a position in TGTX in Q1 2017 and held it in 7 quarters. The position peaked at $1.4M in Q1 2018. 115 funds tracked by Wall St. Rank hold TGTX as of Q4 2018.

  • GAM Holding reported no remaining TG Therapeutics position as of Q4 2018 after selling out during the quarter.
  • GAM Holding sold 98,600 TG Therapeutics shares in Q4 2018, an estimated $552K.
  • GAM Holding first reported a position in TG Therapeutics in Q1 2017 and held it in 7 quarters.
  • GAM Holding's TG Therapeutics position peaked at $1.4M in Q1 2018.
  • 115 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2018.

Based on GAM Holding's 13F filing for Q4 2018, filed 8 Feb 2019.